Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Older Adults

Clinical trial NCT05297578 · COMPLETED

Trial details

NCT number: NCT05297578
Sponsor: Vaxcyte, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pneumococcal Vaccines

Start date: 2022-06-15
Primary completion: 2023-02-15
Enrollment: 207

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.